Possible Potentiating Effects of Combined Administration of Alcohol, Caffeine, and Nicotine on In Vivo Dopamine Release in Addiction-Related Circuits Within the CNS of Rats

Overview

Journal Biomedicines

Specialty Biomedical Engineering

Date 2024 Nov 27

PMID 39595157

Authors

Carmen Costas-Ferreira

Martino Barreiro-Chapela

Rafael Duran

Lilian R Ferreira Faro

Affiliations

Soon will be listed here.

Abstract

Background: Studies that assess the effects of the interaction of psychoactive substances on dopamine release, the key neurotransmitter in the neurochemical and behavioral effects related to drug consumption, are crucial to understand both their roles and the dysfunctions they produce in the central nervous system.

Objective: We evaluated the effects of individual and combined administration of the three most widely consumed psychoactive substances in the world, ethanol, caffeine, and nicotine, on dopaminergic neurotransmission in three brain regions of rats related to addiction: the prefrontal cortex (PFC), the nucleus accumbens (NAcc), and the dorsal striatum.

Methods: The dopamine levels were measured in vivo by cerebral microdialysis associated with HPLC-ED.

Results: We observed that local administration of a single concentration of caffeine (5 mM) or nicotine (5 mM) significantly increased the dopamine levels in all three areas studied, while ethanol (300 mM) increased them in the NAcc and striatum. Perfusion of nicotine + caffeine produced a synergistic effect in both the NAcc and striatum, with increases in the in vivo dopamine release greater than the sum of the effects of both substances. When administering the combination of nicotine + caffeine + ethanol, we observed an additive effect in the NAcc, while in the PFC we observed a synergistic effect.

Conclusions: Our results support the stimulating effects of caffeine, nicotine, and ethanol on the brain reward system. In addition, we also observed that the administration of different mixtures of these substances produces synergistic and additive effects on the release of dopamine in the mesocortical and nigrostriatal systems.

References

Gotti C, Guiducci S, Tedesco V, Corbioli S, Zanetti L, Moretti M . Nicotinic acetylcholine receptors in the mesolimbic pathway: primary role of ventral tegmental area alpha6beta2* receptors in mediating systemic nicotine effects on dopamine release, locomotion, and reinforcement. J Neurosci. 2010; 30(15):5311-25. PMC: 6632743. DOI: 10.1523/JNEUROSCI.5095-09.2010. View

Clarke R, Soderpalm B, Lotfi A, Ericson M, Adermark L . Involvement of Inhibitory Receptors in Modulating Dopamine Signaling and Synaptic Activity Following Acute Ethanol Exposure in Striatal Subregions. Alcohol Clin Exp Res. 2015; 39(12):2364-74. DOI: 10.1111/acer.12895. View

Quarta D, Ferre S, Solinas M, You Z, Hockemeyer J, Popoli P . Opposite modulatory roles for adenosine A1 and A2A receptors on glutamate and dopamine release in the shell of the nucleus accumbens. Effects of chronic caffeine exposure. J Neurochem. 2004; 88(5):1151-8. DOI: 10.1046/j.1471-4159.2003.02245.x. View

Faro L, Costas-Ferreira C, Pantoja A, Duran R . Protective effects of antioxidants on striatal dopamine release induced by organophosphorus pesticides. Pestic Biochem Physiol. 2022; 182:105035. DOI: 10.1016/j.pestbp.2022.105035. View

Di Chiara G . Drug addiction as dopamine-dependent associative learning disorder. Eur J Pharmacol. 1999; 375(1-3):13-30. DOI: 10.1016/s0014-2999(99)00372-6. View

Rossi S, Singer S, Shearman E, Sershen H, Lajtha A . The effects of cholinergic and dopaminergic antagonists on nicotine-induced cerebral neurotransmitter changes. Neurochem Res. 2005; 30(4):541-58. DOI: 10.1007/s11064-005-2689-x. View

Meyer E, Yoshikami D, McIntosh J . The neuronal nicotinic acetylcholine receptors alpha 4* and alpha 6* differentially modulate dopamine release in mouse striatal slices. J Neurochem. 2008; 105(5):1761-9. PMC: 2527994. DOI: 10.1111/j.1471-4159.2008.05266.x. View

Rushworth M, Noonan M, Boorman E, Walton M, Behrens T . Frontal cortex and reward-guided learning and decision-making. Neuron. 2011; 70(6):1054-69. DOI: 10.1016/j.neuron.2011.05.014. View

Yoshimoto K, Ueda S, Kato B, Takeuchi Y, Kawai Y, Noritake K . Alcohol enhances characteristic releases of dopamine and serotonin in the central nucleus of the amygdala. Neurochem Int. 2000; 37(4):369-76. DOI: 10.1016/s0197-0186(00)00037-1. View

10.

Quik M, Perez X, Grady S . Role of α6 nicotinic receptors in CNS dopaminergic function: relevance to addiction and neurological disorders. Biochem Pharmacol. 2011; 82(8):873-82. PMC: 3264546. DOI: 10.1016/j.bcp.2011.06.001. View

11.

Yager L, Garcia A, Wunsch A, Ferguson S . The ins and outs of the striatum: role in drug addiction. Neuroscience. 2015; 301:529-41. PMC: 4523218. DOI: 10.1016/j.neuroscience.2015.06.033. View

12.

Ferre S, Fredholm B, Morelli M, Popoli P, Fuxe K . Adenosine-dopamine receptor-receptor interactions as an integrative mechanism in the basal ganglia. Trends Neurosci. 1997; 20(10):482-7. DOI: 10.1016/s0166-2236(97)01096-5. View

13.

Solinas M, Ferre S, You Z, Karcz-Kubicha M, Popoli P, Goldberg S . Caffeine induces dopamine and glutamate release in the shell of the nucleus accumbens. J Neurosci. 2002; 22(15):6321-4. PMC: 6758129. DOI: 20026640. View

14.

Becker J, Prendergast B, Liang J . Female rats are not more variable than male rats: a meta-analysis of neuroscience studies. Biol Sex Differ. 2016; 7:34. PMC: 4962440. DOI: 10.1186/s13293-016-0087-5. View

15.

Alfonso M, Duran R, Campos F, Perez-Vences D, Faro L, Arias B . Mechanisms underlying domoic acid-induced dopamine release from striatum: an in vivo microdialysis study. Neurochem Res. 2003; 28(10):1487-93. DOI: 10.1023/a:1025614223684. View

16.

Abrahao K, Salinas A, Lovinger D . Alcohol and the Brain: Neuronal Molecular Targets, Synapses, and Circuits. Neuron. 2017; 96(6):1223-1238. PMC: 6566861. DOI: 10.1016/j.neuron.2017.10.032. View

17.

Nakaso K, Ito S, Nakashima K . Caffeine activates the PI3K/Akt pathway and prevents apoptotic cell death in a Parkinson's disease model of SH-SY5Y cells. Neurosci Lett. 2008; 432(2):146-50. DOI: 10.1016/j.neulet.2007.12.034. View

18.

Faro L, Justo L, Alfonso M, Duran R . Possible synergies between isatin, an endogenous MAO inhibitor, and antiparkinsonian agents on the dopamine release from striatum of freely moving rats. Neuropharmacology. 2020; 171:108083. DOI: 10.1016/j.neuropharm.2020.108083. View

19.

Hauser T, Eldar E, Dolan R . Separate mesocortical and mesolimbic pathways encode effort and reward learning signals. Proc Natl Acad Sci U S A. 2017; 114(35):E7395-E7404. PMC: 5584432. DOI: 10.1073/pnas.1705643114. View

20.

Crummy E, ONeal T, Baskin B, Ferguson S . One Is Not Enough: Understanding and Modeling Polysubstance Use. Front Neurosci. 2020; 14:569. PMC: 7309369. DOI: 10.3389/fnins.2020.00569. View